Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 15, 2021

SELL
$25.71 - $35.24 $244,245 - $334,780
-9,500 Closed
0 $0
Q1 2021

May 17, 2021

SELL
$25.89 - $44.46 $78,420 - $134,669
-3,029 Reduced 24.18%
9,500 $292,000
Q4 2020

Feb 16, 2021

SELL
$23.42 - $39.5 $111,736 - $188,454
-4,771 Reduced 27.58%
12,529 $430,000
Q3 2020

Nov 16, 2020

BUY
$21.55 - $33.92 $372,815 - $586,816
17,300 New
17,300 $532,000

Others Institutions Holding RPTX

About Repare Therapeutics Inc.


  • Ticker RPTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 41,937,800
  • Market Cap $148M
  • Description
  • Repare Therapeutics Inc., a clinical-stage precision oncology company, discovers and develops therapeutics by using its synthetic lethality approach in Canada and the United States. The company uses its SNIPRx, a proprietary, genome-wide, and CRISPR-enabled platform to systematically discover and develop highly targeted cancer therapies that foc...
More about RPTX
Track This Portfolio

Track Susquehanna Fundamental Investments, LLC Portfolio

Follow Susquehanna Fundamental Investments, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna Fundamental Investments, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna Fundamental Investments, LLC with notifications on news.